$1.7 Billion Recombinant Proteins Markets, 2021-2026 - Increasing Focus on Biomarker Discovery
05 mars 2021 05h43 HE
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
Worldwide Glycobiology Industry to 2025 - Impact Analysis of COVID-19
11 nov. 2020 06h23 HE
|
Research and Markets
Dublin, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The "Global Glycobiology Market By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate kinases,...
Global Kinase Inhibitors Markets 2019-2020 & 2027 - Surge in Product Approvals & Increase in Incident of Cancer Diseases
09 sept. 2020 06h58 HE
|
Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Kinase Inhibitors - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Kinase Inhibitors...
MolecularMD Corp. Obtains Exclusive License to LKB1 Uses in Non-Small Cell Lung Cancer
28 janv. 2013 08h30 HE
|
MolecularMD
PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...